OTCMKTS:PTCHF PureTech Health (PTCHF) Stock Price, News & Analysis → The attacks will come for me after releasing this… (From Porter & Company) (Ad) Free PTCHF Stock Alerts $2.77 0.00 (0.00%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$2.71▼$2.8150-Day Range$2.55▼$2.9552-Week Range$1.69▼$3.10Volume1,151 shsAverage Volume37,297 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get PureTech Health alerts: Email Address Ad Behind the MarketsWill this AI Micro-Cap be Bigger than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout AI stock. But right now... There's only ONE AI stock you should be watching.Get the full story here >>> About PureTech Health Stock (OTCMKTS:PTCHF)PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.Read More PTCHF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PTCHF Stock News HeadlinesMay 23, 2024 | finance.yahoo.comPureTech to Present at the Jefferies Global Healthcare ConferenceMay 20, 2024 | markets.businessinsider.comPureTech Health Sets $100 Mln Capital Return To ShareholdersMay 20, 2024 | finance.yahoo.comPureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary ShareMay 10, 2024 | morningstar.comPureTech Health PLC PTCHFMay 9, 2024 | finance.yahoo.comPureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual MeetingApril 30, 2024 | finance.yahoo.comPureTech Health plc (NASDAQ:PRTC) Q4 2023 Earnings Call TranscriptApril 9, 2024 | bizjournals.comPureTech’s founding CEO takes new role as head of Boston biotechMarch 23, 2024 | seekingalpha.comPureTech Health: Repeat What WorksMarch 13, 2024 | lse.co.ukPureTech Health celebrates drug designation for LYT-200 from US FDAMarch 13, 2024 | markets.businessinsider.comPureTech Health Gets FDA's Orphan Drug Designation For LYT-200 In Acute Myeloid LeukemiaFebruary 24, 2024 | finance.yahoo.comPureTech Health plc (PTCHF)December 20, 2023 | finance.yahoo.comPureTech Year End Update and Outlook for 2024December 16, 2023 | morningstar.comPureTech Health PLC PRTCAugust 29, 2023 | lse.co.ukPureTech narrows interim loss despite "stormy market challenges"August 1, 2023 | marketwatch.comPureTech Health Gets $11.4Mln to Advance Development of LYT-300June 13, 2023 | finance.yahoo.comResults of PureTech's Annual General MeetingJune 7, 2023 | lse.co.ukPureTech Health's Akili launches ADHD immersive treatment in USMay 9, 2023 | finance.yahoo.comPureTech Founded Entity Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease WeekMay 4, 2023 | finance.yahoo.comPureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based TherapeuticApril 29, 2023 | finance.yahoo.comFull Year 2023 PureTech Health PLC Earnings CallApril 28, 2023 | lse.co.ukPureTech Health yearly loss widens but remains optimisticMarch 25, 2023 | proactiveinvestors.comNike, UBS, MGC Pharmaceuticals, NVIDIA, Travelzoo top the analyst calls of the weekMarch 21, 2023 | lse.co.ukPureTech Health says Karuna KArXT trial receives positive resultsFebruary 14, 2023 | finance.yahoo.comPureTech to Advance LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders and Postpartum DepressionJanuary 21, 2023 | reuters.comPRTC.L - | Stock Price & Latest News | ReutersSee More Headlines Receive PTCHF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:PTCHF CUSIPN/A CIK1782999 Webwww.puretechhealth.com Phone(617) 482-2333FaxN/AEmployees90Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesDr. Bharatt M. Chowrira J.D. (Age 59)Ph.D., CEO & Executive Director Comp: $2.19MMs. Daphne Zohar (Age 53)Founder, Senior Advisor & Board Observer Comp: $3.99MDr. Robert S. Langer Jr. (Age 75)Ph.D., Co-Founder & Non-Executive Director Comp: $135kDr. Eric Elenko Ph.D. (Age 51)President Dr. David R. Elmaleh Ph.D. (Age 76)Co-Founder & Senior Advisor Mr. Eric Green M.B.A.Chief Operating OfficerMs. Allison Mead TalbotHead of Communications & Investor RelationsMr. Charles Sherwood IIIJ.D., Ph.D., General Counsel & Company SecretaryMr. Spencer BallSenior Vice President of Human ResourcesMs. Aleksandra Filipovic M.D.Ph.D., Head of OncologyMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors PTCHF Stock Analysis - Frequently Asked Questions How have PTCHF shares performed in 2024? PureTech Health's stock was trading at $2.38 at the beginning of the year. Since then, PTCHF shares have increased by 16.3% and is now trading at $2.7680. View the best growth stocks for 2024 here. Are investors shorting PureTech Health? PureTech Health saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 8,600 shares, a decrease of 63.1% from the May 15th total of 23,300 shares. Based on an average daily volume of 102,900 shares, the short-interest ratio is currently 0.1 days. View PureTech Health's Short Interest. How do I buy shares of PureTech Health? Shares of PTCHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PTCHF) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.